-
市场
-
产品
-
资讯
-
Moo社区
-
课堂
-
查看更多
-
功能介绍
-
费用费用透明,无最低余额限制
投资选择、功能介绍、费用相关信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 浅色
5 Value Stocks To Watch In The Healthcare Sector
5 Value Stocks To Watch In The Healthcare Sector
Â
The Meaning Behind Value Stocks
A value stock is traditionally defined in terms of how investors in the marketplace are valuing that company's future growth prospects. Low P/E multiples are good base indicators that the company is undervalued and can most likely be labelled as a value stock.
The following stocks are considered to be notable value stocks in the healthcare sector:
- Iterum Therapeutics (NASDAQ:ITRM) - P/E: 1.13
- Viracta Therapeutics (NASDAQ:VIRX) - P/E: 2.89
- Achilles Therapeutics (NASDAQ:ACHL) - P/E: 0.51
- CVRx (NASDAQ:CVRX) - P/E: 0.14
- Cross Country Healthcare (NASDAQ:CCRN) - P/E: 4.23
Iterum Therapeutics saw a decrease in earnings per share from -0.02 in Q4 to $-0.03 now. Viracta Therapeutics has reported Q1 earnings per share at $-0.28, which has increased by 9.68% compared to Q4, which was -0.31. Achilles Therapeutics has been featured as a value stock. Achilles Therapeutics's Q1 EPS sits at $-0.45, which has not changed since last quarter (Q4). CVRx saw a decrease in earnings per share from -0.49 in Q1 to $-0.54 now. Cross Country Healthcare saw a decrease in earnings per share from 1.7 in Q1 to $1.4 now.
These 5 value stocks were selected by Benzinga Insights based on quantified analysis. While this methodical judgment process is not meant to make final decisions, our technology can give investors additional perception into the sector.
Â
Â
The Meaning Behind Value Stocks
价值型股票背后的意义
A value stock is traditionally defined in terms of how investors in the marketplace are valuing that company's future growth prospects. Low P/E multiples are good base indicators that the company is undervalued and can most likely be labelled as a value stock.
传统上,价值型股票的定义是市场上的投资者如何评估该公司未来的增长前景。较低的市盈率是表明该公司被低估的良好基本指标,很可能被贴上价值股的标签。
The following stocks are considered to be notable value stocks in the healthcare sector:
以下股票被认为是医疗保健板块中值得注意的价值股:
- Iterum Therapeutics (NASDAQ:ITRM) - P/E: 1.13
- Viracta Therapeutics (NASDAQ:VIRX) - P/E: 2.89
- Achilles Therapeutics (NASDAQ:ACHL) - P/E: 0.51
- CVRx (NASDAQ:CVRX) - P/E: 0.14
- Cross Country Healthcare (NASDAQ:CCRN) - P/E: 4.23
- Iterum治疗学纳斯达克:ITRM)-市盈率:1.13
- 维拉克塔治疗公司(纳斯达克:virx)-市盈率:2.89
- 阿喀琉斯治疗学纳斯达克:ACHL-市盈率:0.51
- CVRx(纳斯达克:CVRx)-市盈率:0.14
- 越野医疗(纳斯达克:CCRN)-市盈率:4.23
Iterum Therapeutics saw a decrease in earnings per share from -0.02 in Q4 to $-0.03 now. Viracta Therapeutics has reported Q1 earnings per share at $-0.28, which has increased by 9.68% compared to Q4, which was -0.31. Achilles Therapeutics has been featured as a value stock. Achilles Therapeutics's Q1 EPS sits at $-0.45, which has not changed since last quarter (Q4). CVRx saw a decrease in earnings per share from -0.49 in Q1 to $-0.54 now. Cross Country Healthcare saw a decrease in earnings per share from 1.7 in Q1 to $1.4 now.
Iterum治疗公司的每股收益从第四季度的-0.02美元下降到现在的-0.03美元。维拉克塔治疗公司公布第一季度每股收益为-0.28美元,与第四季度的-0.31美元相比增长了9.68%。阿喀琉斯治疗公司一直被列为价值型股票。阿喀琉斯治疗公司第一季度每股收益为-0.45美元,自上一季度以来一直没有变化(第四季度)。CVRx的每股收益从第一季度的-0.49美元下降到现在的-0.54美元。CrossCountry Healthcare的每股收益从第一季度的1.7美元下降到现在的1.4美元。
These 5 value stocks were selected by Benzinga Insights based on quantified analysis. While this methodical judgment process is not meant to make final decisions, our technology can give investors additional perception into the sector.
这5只价值型股票是由Benzinga洞察基于量化分析。虽然这种有条不紊的判断过程并不意味着做出最终决定,但我们的技术可以让投资者对该行业有更多的看法。
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
风险及免责提示
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用浏览器的分享功能,分享给你的好友吧